Home
Live Updates
DENALI Study Seeks to Prove Efficacy of Azenosertib in High-Grade Serous Ovarian Cancer : vimarsana.com
DENALI Study Seeks to Prove Efficacy of Azenosertib in High-Grade Serous Ovarian Cancer
The phase 2 DENALI trial is investigating azenosertib in patients with high-grade serous ovarian cancer.
Related Keywords
Texas ,
United States ,
Houston ,
Shannonn Westin ,
,
Department Of Gynecologic Oncology ,
Womens Health ,
University Of Texas Md Anderson Cancer Center ,
Zentalis Pharmaceuticals ,
Division Of Surgery ,
Gynecologic Oncology ,
Reproductive Medicine ,
Cancer Center ,
Demonstrates Preliminary Efficacy ,
Denali Trial ,
Azenosertib ,
vimarsana.com © 2020. All Rights Reserved.